MEAGHAN EDDY: Open Payments
NPI 1639421027 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 17 payments from 8 companies in 2025. Trend: 2023 $1,231 · 2024 $644 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Ardelyx, Inc. | 3 | $80 |
| Janssen Biotech, Inc. | 2 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 2 | $43 |
| GENZYME CORPORATION | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: IBSRELA, DUPIXENT, TREMFYA, ZENPEP, REZDIFFRA, RINVOQ, MAVYRET, CREON.
Industry payments across NC — which companies pay providers there.
